Kun elektronisk udgave - Sundhedsstyrelsen

Bilag 7ReferencerThe Age-Related Eye Disease Study Research Group. A randomized, placebocontrolled,clinical trial of high-dose supplementation with vitaminsC and E and betacarotene for age-related cataract and vision loss: AREDSreport no. 8. Arch Ophthalmol 2001;119:1417-1436. (1)Alban et al. Retningslinier for udarbejdelse af økonomiske analyser aflægemidler. Bilag 1 i Sundhedsministeriet. Udfordringer på lægemiddelområdet.Betænkning afgivet af Sundhedsministeriets Medicinudvalg.Sundhedsministeriet, København, juni 1998. (2)Algvere PV, Berglin L, Gouras P, Sheng Y. Transplantation of fetal retinalpigment epithelium in age-related macular degeneration with subfovealneovascularization. Graefes Arch Clin Exp Ophthalmol 1994;232:707-16.(3)Allikmets R et al. Mutation af the Stargardt disease gene (ABCR) in agerelatedmacaular degeneration. Science 1997; sept. 277(5333):1805-7. (4)The Alpha-Tocopherol BCCPSG. The effect of Vitamine E and beta caroteneon the incidence of lung cancer and other cancers in male smokers. NEng J Med. 1994;330(15):1029-35. (5)Armbrecht et al. Is cataract surgery justified in patients with age relatedmacular degeneration? A visual function and quality of life assessment. BrJ Ophthalmol 2000;84:1343-1348. (6)Augsburger JJ. External beam radiation is not effective in the treatment ofage-related macular degeneration. Arch Ophthalmol 1998;116:1509-11.(7)Berger J. Wavelength considerations for laser prophylaxis in AMD. Ophthalmol2000;107:1019-1021. (8)Bird AC, Bressler NM, Bressler SB et al. An international classificationand grading system for age-related maculopathy and age-related maculardegeneration. Surv Ophthalmol 1995;39:367-374. (9)Blumenkranz MS. TAP 24-months topline data. Http://www.visudyne.wwwepposium.com/pw/html/index.html(10)Blumenkranz MS. ARVO 2001, Fort Lauderdale, FL, USA. Http://www.visudyne.wwwepposium.com (11)79